| Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. | |
| | |
MedLine Citation:
|
PMID: 12957766 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Mild anaemia frequently occurs in patients with chronic heart failure (CHF), particularly in the advanced stages of the disease. The correction of anaemia with erythropoietin is a therapeutic possibility. The aim of this study was to assess prospectively the relationship between the prevalence of anaemia (haemoglobin level<or=120 g/l) and prognosis in an unselected CHF population. METHODS: All consecutive patients with a diagnosis of CHF admitted to our department between January 2000 and April 2000 were considered for the present study. Those with secondary causes of anaemia were excluded. Patients were followed up until November 2001 (>18 months in all survivors), and the end-point of the study was all-cause mortality. RESULTS: A total of 176 patients were enrolled (mean age: 63 years, New York Heart Association (NYHA) classification I/II/III/IV: 15/81/51/29; left ventricular ejection fraction (LVEF): 42%, ischaemic aetiology in 62%). In the whole population the mean haemoglobin level was 140+/-15 g/l. Anaemia was found in 18 (10%) patients, and was significantly more common in women than in men (18 vs. 7%, respectively, P=0.02) and in those with most severe CHF symptoms (frequency in NYHA I/II/III/IV: 0/9/10/21%, respectively; NYHA IV vs. I-III, P=0.03), but not related to the other clinical indices. Univariate analysis revealed NYHA class III-IV (hazard ratio 3.8, 95% CI: 1.6-8.9, P=0.003), low LVEF <35% (hazard ratio 2.3, 95% CI: 1.0-4.9, P=0.04) and anaemia (hazard ratio 2.9, 95% CI: 1.2-7.2, P=0.02) as predictors of 18-month mortality. In multivariate analysis, anaemia remained an independent predictor of death when adjusted for NYHA class and LVEF (hazard ratio: 2.6, 95% CI: 1.0-6.5, P=0.04). In anaemic patients, 18-month survival was 67% (95% CI: 45-89%) compared to 87% (81-92%) in patients with a normal haemoglobin level (P=0.016). CONCLUSIONS: Mild anaemia is a significant and independent predictor of poor outcome in unselected patients with CHF. Correction of low haemoglobin level may become an interesting therapeutic option for CHF patients. |
| | |
Authors:
|
J Szachniewicz; J Petruk-Kowalczyk; J Majda; A Kaczmarek; K Reczuch; P R Kalra; M F Piepoli; S D Anker; W Banasiak; P Ponikowski |
Related Documents
:
|
10071256 - Long-term morbidity and mortality trials with amlodipine. 21244736 - Nasal polyps: an independent risk factor for bronchial hyperresponsiveness in patients ... 4050656 - Spontaneous echographic contrast in the inferior vena cava. 10759256 - Cardiovascular autonomic function in patients with primary achalasia. 6720516 - Programmed ventricular stimulation in patients without spontaneous ventricular tachycar... 15668266 - Fdg-pet scanning for detection and staging of extranodal marginal zone lymphomas of the... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of cardiology Volume: 90 ISSN: 0167-5273 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2003 Aug |
Date Detail:
|
Created Date: 2003-09-05 Completed Date: 2003-12-09 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 303-8 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Military Hospital, ul Weigla 5, 50-891 Wroclaw, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analysis of Variance Anemia / epidemiology, etiology* Female Heart Failure / complications* Humans Male Middle Aged Prevalence Prognosis Proportional Hazards Models Prospective Studies Statistics, Nonparametric |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coro...
Next Document: Coronary artery bypass surgery in patients with severe left ventricular dysfunction.